NAS:FWP (Denmark)  
Forward Pharma A/S logo

Forward Pharma A/S

$ 2.89 +0.01 (+0.35%) 02:13 PM EST
P/E:
At Loss
P/B:
0.29
Market Cap:
$ 20.49M
Enterprise V:
$ -50.35M
Volume:
780.00
Avg Vol (2M):
3.81K
Also Trade In:
Volume:
780.00
Market Cap $:
20.49M
PE Ratio:
At Loss
Avg Vol (2-Month):
3.81K
Enterprise Value $:
-50.35M
PB Ratio:
0.29
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Forward Pharma A/S is a biopharmaceutical company that engages in the research and production of medicinal treatments for multiple sclerosis and psoriasis.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.99
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score -3.4
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 22.19
9-Day RSI 22.62
14-Day RSI 25.67
6-1 Month Momentum % -36.08
12-1 Month Momentum % -41.69

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 117.44
Quick Ratio 117.44
Cash Ratio 116.4

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -1.1

Financials

FWP's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:FWP

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -0.28
Beta 0.89
Volatility % 27.13
14-Day RSI 25.67
14-Day ATR ($) 0.140509
20-Day SMA ($) 3.26272
12-1 Month Momentum % -41.69
52-Week Range ($) 2.88 - 7.22
Shares Outstanding (Mil) 7.09

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Forward Pharma A/S Filings

Document Form Filing Date
No Filing Data

Forward Pharma A/S Analysis

Share your research

Headlines

See More
No news.